Cargando…
Genetic heterogeneity in patients with Bartter syndrome type 1
Bartter syndrome (BS) type 1 is an autosomal recessive kidney disorder caused by loss-of-function mutations in the solute carrier family 12 member 1 (SLC12A1) gene. To date, 72 BS type 1 patients harboring SLC12A1 mutations have been documented. Of these 144 alleles studied, 68 different disease-cau...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364841/ https://www.ncbi.nlm.nih.gov/pubmed/28000888 http://dx.doi.org/10.3892/mmr.2016.6063 |
_version_ | 1782517403990622208 |
---|---|
author | Sun, Mingran Ning, Jing Xu, Weihong Zhang, Han Zhao, Kaishu Li, Wenfu Li, Guiying Li, Shibo |
author_facet | Sun, Mingran Ning, Jing Xu, Weihong Zhang, Han Zhao, Kaishu Li, Wenfu Li, Guiying Li, Shibo |
author_sort | Sun, Mingran |
collection | PubMed |
description | Bartter syndrome (BS) type 1 is an autosomal recessive kidney disorder caused by loss-of-function mutations in the solute carrier family 12 member 1 (SLC12A1) gene. To date, 72 BS type 1 patients harboring SLC12A1 mutations have been documented. Of these 144 alleles studied, 68 different disease-causing mutations have been detected in 129 alleles, and no mutation was detected in the remaining 15 alleles. The mutation types included missense/nonsense mutations, splicing mutations and small insertions and deletions ranging from 1 to 4 nucleotides. A large deletion encompassing a whole exon in the SLC12A1 gene has not yet been reported. The current study initially identified an undocumented homozygous frameshift mutation (c.1833delT) by Sanger sequencing analysis of a single infant with BS type 1. However, in a subsequent analysis, the mutation was detected only in the father's DNA. Upon further investigation using a next-generation sequencing approach, a deletion in exons 14 and 15 in both the patient and patient's mother was detected. The deletion was subsequently confirmed by use of a long-range polymerase chain reaction and was determined to be 3.16 kb in size based on sequencing of the junction fragment. The results of the present study demonstrated that pathogenic variants of SLC12A1 are heterogeneous. Large deletions appear to serve an etiological role in BS type 1, and may be more prevalent than previously thought. |
format | Online Article Text |
id | pubmed-5364841 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-53648412017-05-15 Genetic heterogeneity in patients with Bartter syndrome type 1 Sun, Mingran Ning, Jing Xu, Weihong Zhang, Han Zhao, Kaishu Li, Wenfu Li, Guiying Li, Shibo Mol Med Rep Articles Bartter syndrome (BS) type 1 is an autosomal recessive kidney disorder caused by loss-of-function mutations in the solute carrier family 12 member 1 (SLC12A1) gene. To date, 72 BS type 1 patients harboring SLC12A1 mutations have been documented. Of these 144 alleles studied, 68 different disease-causing mutations have been detected in 129 alleles, and no mutation was detected in the remaining 15 alleles. The mutation types included missense/nonsense mutations, splicing mutations and small insertions and deletions ranging from 1 to 4 nucleotides. A large deletion encompassing a whole exon in the SLC12A1 gene has not yet been reported. The current study initially identified an undocumented homozygous frameshift mutation (c.1833delT) by Sanger sequencing analysis of a single infant with BS type 1. However, in a subsequent analysis, the mutation was detected only in the father's DNA. Upon further investigation using a next-generation sequencing approach, a deletion in exons 14 and 15 in both the patient and patient's mother was detected. The deletion was subsequently confirmed by use of a long-range polymerase chain reaction and was determined to be 3.16 kb in size based on sequencing of the junction fragment. The results of the present study demonstrated that pathogenic variants of SLC12A1 are heterogeneous. Large deletions appear to serve an etiological role in BS type 1, and may be more prevalent than previously thought. D.A. Spandidos 2017-02 2016-12-21 /pmc/articles/PMC5364841/ /pubmed/28000888 http://dx.doi.org/10.3892/mmr.2016.6063 Text en Copyright: © Sun et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Sun, Mingran Ning, Jing Xu, Weihong Zhang, Han Zhao, Kaishu Li, Wenfu Li, Guiying Li, Shibo Genetic heterogeneity in patients with Bartter syndrome type 1 |
title | Genetic heterogeneity in patients with Bartter syndrome type 1 |
title_full | Genetic heterogeneity in patients with Bartter syndrome type 1 |
title_fullStr | Genetic heterogeneity in patients with Bartter syndrome type 1 |
title_full_unstemmed | Genetic heterogeneity in patients with Bartter syndrome type 1 |
title_short | Genetic heterogeneity in patients with Bartter syndrome type 1 |
title_sort | genetic heterogeneity in patients with bartter syndrome type 1 |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364841/ https://www.ncbi.nlm.nih.gov/pubmed/28000888 http://dx.doi.org/10.3892/mmr.2016.6063 |
work_keys_str_mv | AT sunmingran geneticheterogeneityinpatientswithbarttersyndrometype1 AT ningjing geneticheterogeneityinpatientswithbarttersyndrometype1 AT xuweihong geneticheterogeneityinpatientswithbarttersyndrometype1 AT zhanghan geneticheterogeneityinpatientswithbarttersyndrometype1 AT zhaokaishu geneticheterogeneityinpatientswithbarttersyndrometype1 AT liwenfu geneticheterogeneityinpatientswithbarttersyndrometype1 AT liguiying geneticheterogeneityinpatientswithbarttersyndrometype1 AT lishibo geneticheterogeneityinpatientswithbarttersyndrometype1 |